##  [Novartis announces FDA approval of Xolair® (omalizumab) for pediatric allergic asthma](/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0 "Novartis announces FDA approval of Xolair® (omalizumab) for pediatric allergic asthma") 

  Jul 07, 2016